Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study.

Genki Sato Hiroshi Uchino Takahisa Hirose

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

Escalating the dose of oral semaglutide to 14 mg could be an effective approach for enhancing glycemic control and managing body weight in individuals with type 2 diabetes.

Keyphrases

body weight
glycemic control
type diabetes
blood glucose
weight loss
cross sectional
insulin resistance
adipose tissue
metabolic syndrome